These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15243865)

  • 1. Therapeutic insight 2004. 3-4 May 2004, Jersey City, NJ, USA.
    Nicoletti A
    IDrugs; 2004 Jul; 7(7):644-7. PubMed ID: 15243865
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotech industry tries to recover from 2-year lull.
    Brower V
    J Natl Cancer Inst; 2003 Mar; 95(5):348-9. PubMed ID: 12618496
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenetics--pivotal to the future of the biopharmaceutical industry.
    Foot E; Kleyn D; Palmer Foster E
    Drug Discov Today; 2010 May; 15(9-10):325-7. PubMed ID: 20298799
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular disease drug discovery.
    Persidis A
    Nat Biotechnol; 1999 Sep; 17(9):930-1. PubMed ID: 10471943
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular disease.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT15-7. PubMed ID: 11221707
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomic sciences and the medicine of tomorrow.
    Drews J
    Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer multidrug resistance.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT18-20. PubMed ID: 11221708
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug development in the Pacific Rim.
    Wong J
    Clin Adv Hematol Oncol; 2006 Sep; 4(9):670-2. PubMed ID: 17099623
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug discovery: playing dirty.
    Frantz S
    Nature; 2005 Oct; 437(7061):942-3. PubMed ID: 16222266
    [No Abstract]   [Full Text] [Related]  

  • 10. Death by inflammation: drug makers chase the master controller.
    Sheridan C
    Nat Biotechnol; 2019 Feb; 37(2):111-113. PubMed ID: 30718870
    [No Abstract]   [Full Text] [Related]  

  • 11. EPIDAUROS Biotechnologie AG.
    Arnold HP; Kluge P; Mauch S
    Pharmacogenomics; 2005 Jul; 6(5):535-8. PubMed ID: 16014003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
    Tear S; Zarkowska T
    IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches.
    Thoenen H; Sendtner M
    Nat Neurosci; 2002 Nov; 5 Suppl():1046-50. PubMed ID: 12403983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new cancer ecosystem.
    Horning SJ
    Science; 2017 Mar; 355(6330):1103. PubMed ID: 28302798
    [No Abstract]   [Full Text] [Related]  

  • 16. Deal-making trends in oncology.
    Moore K; Walker J
    Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644466
    [No Abstract]   [Full Text] [Related]  

  • 17. The carbohydrate-based drug industry.
    Persidis A
    Nat Biotechnol; 1997 May; 15(5):479-80. PubMed ID: 9131631
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetics and drug metabolism.
    Ball S; Borman N
    Nat Biotechnol; 1997 Oct; 15(10):925-6. PubMed ID: 9335033
    [No Abstract]   [Full Text] [Related]  

  • 19. 2011 in reflection.
    Mullard A
    Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotechnology consortia versus multifirm alliances: paradigm shift at work?
    Persidis A; Persidis A
    Nat Biotechnol; 1996 Dec; 14(13):1657-60. PubMed ID: 9634847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.